4594 BrightPath Biotherapeutics Co.,Ltd.ブライトパス・バイオTSE Growth / Pharmaceuticals
0 posts
BrightPath Biotherapeutics Co.,Ltd. (4594) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
BrightPath Biotherapeutics Co.,Ltd. (4594) Stock Price HistoryNear an all-time low
BrightPath Biotherapeutics Co.,Ltd. closed at ¥36.0 on Nov 20, 2026, −12.2% over 1 month, −39.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥87,805 today (−12.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −12.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥36.0 | −2 | −5.26% |
| Nov 19 (Thu) | ¥38.0 | +0 | +0.00% |
| Nov 18 (Wed) | ¥38.0 | −1 | −2.56% |
| Nov 17 (Tue) | ¥39.0 | +1 | +2.63% |
| Nov 16 (Mon) | ¥38.0 | +0 | +0.00% |
| Nov 13 (Fri) | ¥38.0 | −1 | −2.56% |
| Nov 12 (Thu) | ¥39.0 | +0 | +0.00% |
| Nov 11 (Wed) | ¥39.0 | +2 | +5.41% |
| Nov 9 (Mon) | ¥37.0 | +0 | +0.00% |
| Nov 6 (Fri) | ¥37.0 | −2 | −5.13% |
If you had invested ¥100,000 3 months ago, it would be worth ¥65,455 today (−34.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −34.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥36.0 | −2 | −5.26% |
| Nov 19 (Thu) | ¥38.0 | +0 | +0.00% |
| Nov 18 (Wed) | ¥38.0 | −1 | −2.56% |
| Nov 17 (Tue) | ¥39.0 | +1 | +2.63% |
| Nov 16 (Mon) | ¥38.0 | +0 | +0.00% |
| Nov 13 (Fri) | ¥38.0 | −1 | −2.56% |
| Nov 12 (Thu) | ¥39.0 | +0 | +0.00% |
| Nov 11 (Wed) | ¥39.0 | +2 | +5.41% |
| Nov 9 (Mon) | ¥37.0 | +0 | +0.00% |
| Nov 6 (Fri) | ¥37.0 | −2 | −5.13% |
If you had invested ¥100,000 6 months ago, it would be worth ¥70,588 today (−29.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −29.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥36.0 | −10.0% |
| Oct 2026 | ¥40.0 | −20.0% |
| Sep 2026 | ¥50.0 | −5.7% |
| Aug 2026 | ¥53.0 | +6.0% |
| Jul 2026 | ¥50.0 | +8.7% |
| Jun 2026 | ¥46.0 | −11.5% |
| May 2026 | ¥52.0 | −5.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥61,017 today (−39.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −39.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥36.0 | −10.0% |
| Oct 2026 | ¥40.0 | −20.0% |
| Sep 2026 | ¥50.0 | −5.7% |
| Aug 2026 | ¥53.0 | +6.0% |
| Jul 2026 | ¥50.0 | +8.7% |
| Jun 2026 | ¥46.0 | −11.5% |
| May 2026 | ¥52.0 | −5.5% |
| Apr 2026 | ¥55.0 | −20.3% |
| Mar 2026 | ¥69.0 | +4.5% |
| Feb 2026 | ¥66.0 | +3.1% |
| Jan 2026 | ¥64.0 | +33.3% |
| Dec 2025 | ¥48.0 | −14.3% |
| Nov 2025 | ¥56.0 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥36,000 today (−64.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −64.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥36.0 | −25.0% |
| 2025 | ¥48.0 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥30,252 today (−69.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −69.7%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥36.0 | −25.0% |
| 2025 | ¥48.0 | ― |
If you had invested ¥100,000 in Nov 2015, it would be worth ¥10,028 today (−90.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +196.5%, while this stock moved −90.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥36.0 | −25.0% |
| 2025 | ¥48.0 | +6.7% |
| 2024 | ¥45.0 | −48.3% |
| 2023 | ¥87.0 | −13.0% |
| 2022 | ¥100 | −10.7% |
| 2021 | ¥112 | −38.5% |
| 2020 | ¥182 | −41.9% |
| 2019 | ¥313 | +49.0% |
| 2018 | ¥210 | −67.0% |
| 2017 | ¥636 | −8.4% |
| 2016 | ¥694 | +162.9% |
| 2015 | ¥264 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Nov 2015). Please check the latest prices before trading.
BrightPath Biotherapeutics Co.,Ltd. (4594) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of BrightPath Biotherapeutics Co.,Ltd. (4594)
Business overview
The company is a drug discovery venture focused on developing new cancer immunotherapy drugs, with multiple pipeline candidates ranging from exploratory research to early clinical trials. Its business model is to create or in-license new cancer immunotherapies, handle them from exploratory research through early clinical trials, and license out development, manufacturing and sales rights to pharmaceutical companies in Japan and abroad for license revenue. Drug development generally takes more than 10 years to reach market and requires more funding the later the stage, so a mechanism to recover development investment early is important. Before launch it aims to earn upfront payments at signing and milestone revenue at each development stage, and after launch sales royalty revenue. By advancing multiple pipeline candidates at different stages in parallel, it seeks early recovery of investment and continuous revenue after turning profitable.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 2.75x | Above the sector median of 1.86x (No. 52 from the lowest) |
|---|---|---|
| ROE | -101.21% | No. 50 in the sector (highest first); median 4.17% |
| Market cap | ¥5.0 bn | No. 64 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥96 | 3/25 |
|---|---|---|
| 52-week low | ¥36 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥36) |
| Year to date | -25.0% | No. 48 of 77 in the sector (best first) |
| 1 year | -39.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 9/18 (No. 47) |
|---|---|---|
| Top 50 losers | 2 times | Latest: 10/6 (No. 43) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/13 15:32営業外収益及び特別利益の計上に関するお知らせ
- 11/13 15:322027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)
- 11/02 15:30第三者割当による第21回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 10/05 12:30第三者割当による第21回新株予約権(行使価額修正条項付)の発行価額の払込完了に関するお知らせ
- 09/18 16:00第21回新株予約権発行に関する補足説明資料
- 09/18 16:00第三者割当による第21回新株予約権(行使価額修正条項付)の発行及び新株予約権の買取契約の締結に関するお知らせ
Filings from the past 12 months (6).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the BrightPath Biotherapeutics Co.,Ltd. board
More Japanese stocks in English
- MIZUHO MEDY CO.,LTD.4595
- Kubota Pharmaceutical Holdings Co.,Ltd.4596
- Solasia Pharma K.K.4597
- Delta-Fly Pharma,Inc.4598
- StemRIM Inc.4599
- Nomura High-yield J-REIT Index ETF459A
- BRANU Inc.460A
- Dai Nippon Toryo Company,Limited4611
- NIPPON PAINT HOLDINGS CO.,LTD.4612
- KANSAI PAINT CO.,LTD.4613
- SHINTO PAINT COMPANY,LIMITED4615
- KAWAKAMI PAINT MANUFACTURING CO.,LTD.4616